CMM Treatment ApS: Financial statements 2024
CVR: 38553038
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
CMM Treatment ApS (CVR 38553038) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -8,250 and a net result of DKK -8,250 compared with DKK -15,766 the year before. Equity in the 2024 report amounted to DKK 2,780. The solvency ratio was 35.7%.
- Gross Profit
- DKK -8,250
- Profit/Loss
- DKK -8,250
- Equity
- DKK 2,780
- Total Assets
- DKK 7,780
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -8K | -8K | 3K | 0 |
| 2023 | - | -8K | -16K | 11K | 0 |
| 2022 | - | -8K | -6K | 27K | 0 |
| 2021 | - | -8K | -6K | 13K | 0 |
| 2020 | - | -8K | -6K | 19K | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout CMM Treatment ApS
CMM Treatment ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named CMM Treatment IVS. The management consists of Thomas Frilund Jacobsen. The company's owners include Marina Jacobsen, Martin Vetling and Claus Vetling. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -8,500 and a net result of DKK -8,500 compared with DKK -8,250 the year before. Equity in the 2025 report amounted to DKK -5,720.